Introduction
Levosalbutamol sulphate (LSS) is the R -enantiomer of short acting β 2 -adrenergic receptor agonist of Salbutamol. Chemical it is 4[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxy methyl) phenol and its Molecular formula C 13 H 21 NO 3 , Molecular wt. 239.311 g/mol. As a bronchodilator, it is used to treat asthma and COPD 1, 2 . Literature survey reveals that, only few spectrophotometric 3 ,4,5,6,7 and bioanalytical methods by HPLC was found using human plasma urine, blood and biological fluids 8, 9, 10 , GC-MS-SIM 11 and HPLC 12 for the quantitative estimation of Levosalbutamol sulphate in bulk and pharmaceutical formulations have been developed. Hence an attempt has been made to develop new method for its estimation in bulk and pharmaceutical formulation with good accuracy, simplicity and precision. 
Material and Methods

Apparatus
A shimadzu model 1800 double beam UV/ Visible spectrophotometer with spectral width of 1 nm, wavelength accuracy of ± 0.1 nm and a pair of 10 mm matched quartz cell was used to measure absorbance of all the solutions. Spectra were automatically obtained by UV-Probe system software (ver.2.34).
Reagents and Materials
All chemicals and reagents were used of AR grade. Authentic of LSS was obtained as gift samples from Cipla Pharmaceutical Pvt., Ltd. Mumbai.
Selection of detection wavelength
Solutions of drug were scanned over the range of 200-400 nm. It was observed that the drug showed considerable absorbance at 277nm, 232nm and 237nm for zero, first and second order were selected as the wavelength for detection. The spectra of LSS show in fig. 5, 6 and 7.
Preparation of standard stock solutions
LSS was weighed (100mg) and transferred to 100ml volumetric flasks and make up the volume up to the mark with distilled water and the final concentration of solution containing 1000 µg/ml of LSS.
Preparation of working solutions
Aliquot from the stock solutions of LSS was appropriately diluted with distilled water to obtain working standard of LSS.
Method Development and Validation
The method was validated for accuracy, precision, linearity, detection limit, quantitation limit and specificity.
Linearity
The linearity of levosalbutamol was found to be 20-60µg/ml, 5-25µg/ml and 35-55µg/ml for zero, first and second order respectively. The r 2 values were near about 0.999 for all orders which shows good correlation between analyte concentration and response area. The data of regression analysis was shown in table 1 and figure 2, 3, 4. 
Precision
The %RSD obtained for repeatability studies were found to be -0.53-0.73 carried out by estimating response for levosalbutamol. The %RSD for intra-day and inter-day precision was found to be 0.154-1.13 and 0.21-1.5 respectively for levosalbutamol. The RSD values which are well below 2% indicate that the precision of the method is satisfactory. (Table 2 and 3) . 
Accuracy
The mean % recoveries for levosalbutamol zero, first and second order were found to be 99.9, 99.87 and 100.17, respectively (Table 4 ). The % recovery of added drugs is well within the limits of 98-102%. It indicates the accuracy of this method. 
Analysis of market formulations
The assay result obtained by using the proposed method for the analysis of marketed formulations containing levosalbutamol. The results showed in table 5 and 6. The average content of levosalbutamol was found to be 98-100% in acceptance limit. This indicates that present method can be successfully used for the estimation of levosalbutamol. 
Conclusion
Proposed study describes method for the estimation of Levosalbutamol sulphate. The method was validated and found to be simple, sensitive, accurate and precise as per ICH guidelines .The proposed method in routine quality control laboratories for determination of Levosalbutamol sulphate.
